Back to MAI Capital Management MAI Capital Management

ALXNALXN
10 quarters

Position history for MAI Capital ManagementMAI Capital Management's holdings in ALEXION PHARMACEUTICALS INC

MAI Capital Management previously held 0 shares of ALXN (ALEXION PHARMACEUTICALS INC), worth $0 as of 2021-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$925,000

Total Shares Change

-7,061

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%
0
2021-Q2
New
1,189
-
$218,0000.0%
32
2021-Q1
Exited
0
-100.0%
$00.0%
0
2020-Q4
Decreased
1,754
-16.8%
$274,0000.0%
0
2020-Q3
Decreased
2,108
-22.5%
$241,0000.0%
0
2020-Q2
Decreased
2,720
-7.6%
$305,0000.0%
0
2020-Q1
Decreased
2,945
-30.9%
$264,0000.0%
0
2019-Q4
Decreased
4,262
-37.0%
$461,0000.0%
0
2019-Q3
Decreased
6,769
-4.1%
$663,0000.0%
0
2019-Q2
New
7,061
-
$925,0000.0%
35

Other major holders of ALXN: FARALLON CAPITAL MANAGEMENT, L.L.C., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, HBK INVESTMENTS L P

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used